Prevalence and factors influencing sub-optimal serum levels of 25-hydroxyvitamin D among children with sickle cell anaemia in south-west Nigeria
Background: Sub-optimal levels of vitamin D worsens morbidity in sickle cell anaemia (SCA). Increased frequency of pain episodes and haemolysis have been linked with the deficiency and or insufficiency of vitamin D among individuals with SCA. In Nigeria, the country with the highest SCA burden, data on the prevalence and risk factors for sub-optimal vitamin D in SCA is scanty.
Objectives: The objectives of this study were to determine the prevalence of depressed vitamin D and examine the influence of sociodemographic characteristics and anthropometric parameters on the serum levels of 25-hydroxyvitamin D (25-OHD) among Nigerian children with SCA.
Methods: In this cross-sectional comparative study, serum 25-OHD levels of 95 children with SCA and 75 age- and gender-matched haemoglobin AA control were quantified by high performance liquid chromatography over a six-month period.
Results: A higher proportion of children with SCA had sub-optimal 25-OHD compared with the controls: 12.6% vs. 2.7%, p = 0.013, 95% CI = 1.1–24.4. The mean serum 25-OHD of the children with SCA was also significantly lower (41.8 ± 9.8ng/mL vs. 45.2 ±8.1ng/mL, p = 0.017, 95% CI = 1.6 – 6.1). Serum 25-OHD was not related to age, sex, social class, presence of underweight, overweight/obesity and stunting in both bivariate and multivariate analyses.Conclusion: The prevalence of low serum vitamin D was higher among SCA patients than the matched controls. The serum level was not influenced by their sociodemographic and nutritional status.
2. Buison AM, Kawchak DA, Schall J, Ohene-Frempong K, Stallings VA, Zemel BS. Low vitamin D status in children with sickle cell disease. J Pediatr 2004: 145: 622-27.
3. Tayo BO, Akingbola TS, Salako BL, McKenzie CA, Reid M, Layden J, et al. Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa. BMC Hematol 2014; 14: 12.
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
5. Mithal A, Wad DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20: 1807–20.
6. Olusanya O, Okpere E, Ezimokhai M. The importance of social class in voluntary fertility control in a developing country. West Afr J Med 1985; 4: 205-12.
7. WHO. WHO Child Growth Standards; Methods and development: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age. World Health Organization, Geneva. 2006.
8. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, et al. CDC growth charts: United States. Advance data from vital and healthstatistics; no. 314. Hyattsville, Maryland: National Center for Health Statistics, 2000.
9. Frisancho A. Anthropometric standards for the assessment of growth and nutritional status. Ann Arbor, MI: University of Michigan Press, 1990.
10. Pfitzner MA, Thacher TD, Pettifor JM, Zoakah AI, Lawson JO, Isichei CO, et al. Absence of vitamin D deficiency in young Nigerian children. J Pediatr 1998; 133: 740-44.
11. Oginni LM, Worsfold M, Oyelami OA, Sharp CA, Powell DE, Davie MWJ. Etiology of rickets in Nigerian children. J Pediatr 1996; 128: 692-94.
12. Osunkwo I, Ziegler TR, Alvanez J, McCracken C, Cherry K, Osunkwo CE, et al. High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomised double blind pilot study. Br J Haematol 2012; 159(2): 211-15.
13. Rovner AJ, Stallings VA, Kawchak DA, Schall JI, Ohene-Frempong K, Zemel BS. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 2008; 108: 1512-16.
14. Jackson TC, Krauss MJ, DeBaun MR, Strunk RC, Arbeláez AM. Vitamin-D deficiency and comorbidities in children with sickle cell anemia. Pediatr Hematol Oncol 2012; 29: 261-66.
15. Garrido C, Cela E, Beléndez C, Mata C, Huerta J. Status of vitamin D in children with sickle cell disease living in Madrid, Spain. Eur J Pediatr 2012; 171: 1793-98.
16. Ozen S, Unal S, Ercetin N, Tasdelen B. Frequency and risk factors of endocrine complications in Turkish children and adolescents with sickle cell anemia. Turk J Haematol 2013; 30: 25–31.
17. Mohammed S, Addae S, Suleiman S, Adzaku F, Annobil S, Kaddoumi O, et al. Serum calcium, parathyroid hormone, and vitamin D status in children and young adults with sickle cell disease. Ann Clin Biochem 1993; 30 Pt 1: 45–51.
18. van der Dijs FP, van der Klis FR, Muskiet FD, Muskiet FA. Serum calcium and vitamin D status of patients with sickle cell disease in Curacao. Ann Clin Biochem 1997; 34 Pt 2: 170–72.
19. de Oliveira JF, Vicente NG, Santos JP, Weffort VR. Vitamin D in children and adolescents with SCD: an integrative review. Rev Paul Pediatr 2015; 33(3): 349-54.
20. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Bone mineral density in children with sickle cell anaemia. Pediatr Blood Cancer 2006; 47: 901-06.
21. Peters BSE, dos Santos LC, Fisberg M, Wood RJ, Martini LA. Prevalence of vitamin D insufficiency in Brazilian adolescents. Ann Nutr Metab 2009; 54: 15-21.
22. van der Gaag, Brekhoff L. Effects of food and vitamin D supplements on the serum 25(OHD)3 concentration in children during winter months. Foods 2014; 3: 632–41.
The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.